Semmax Financial Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,849
| Closed | -$18.4K | – | 437 |
|
|
2025
Q1 | $18.4K | Hold |
1,849
| – | – | 0.01% | 206 |
|
|
2024
Q4 | $16.3K | Hold |
1,849
| – | – | ﹤0.01% | 198 |
|
|
2024
Q3 | $14.5K | Hold |
1,849
| – | – | ﹤0.01% | 198 |
|
|
2024
Q2 | $14.6K | Hold |
1,849
| – | – | ﹤0.01% | 214 |
|
|
2024
Q1 | $10.4K | Hold |
1,849
| – | – | ﹤0.01% | 206 |
|
|
2023
Q4 | $9.84K | Hold |
1,849
| – | – | ﹤0.01% | 213 |
|
|
2023
Q3 | $9.52K | Buy |
+1,849
| New | +$9.52K | ﹤0.01% | 194 |
|
|
2022
Q4 | $18K | Hold |
1,849
| – | – | 0.01% | 155 |
|
|
2022
Q3 | $22K | Hold |
1,849
| – | – | 0.01% | 140 |
|
|
2022
Q2 | $27K | Buy |
1,849
+150
| +9% | +$2.19K | 0.01% | 133 |
|
|
2022
Q1 | $28K | Buy |
1,699
+1,352
| +390% | +$22.3K | 0.01% | 152 |
|
|
2021
Q4 | $5K | Hold |
347
| – | – | ﹤0.01% | 208 |
|
|
2021
Q3 | $5K | Buy |
+347
| New | +$5K | ﹤0.01% | 196 |
|